Cargando…

Hydroxychloroquine and tocilizumab therapy in COVID-19 patients—An observational study

Hydroxychloroquine has been touted as a potential COVID-19 treatment. Tocilizumab, an inhibitor of IL-6, has also been proposed as a treatment of critically ill patients. In this retrospective observational cohort study drawn from electronic health records we sought to describe the association betwe...

Descripción completa

Detalles Bibliográficos
Autores principales: Ip, Andrew, Berry, Donald A., Hansen, Eric, Goy, Andre H., Pecora, Andrew L., Sinclaire, Brittany A., Bednarz, Urszula, Marafelias, Michael, Berry, Scott M., Berry, Nicholas S., Mathura, Shivam, Sawczuk, Ihor S., Biran, Noa, Go, Ronaldo C., Sperber, Steven, Piwoz, Julia A., Balani, Bindu, Cicogna, Cristina, Sebti, Rani, Zuckerman, Jerry, Rose, Keith M., Tank, Lisa, Jacobs, Laurie G., Korcak, Jason, Timmapuri, Sarah L., Underwood, Joseph P., Sugalski, Gregory, Barsky, Carol, Varga, Daniel W., Asif, Arif, Landolfi, Joseph C., Goldberg, Stuart L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425928/
https://www.ncbi.nlm.nih.gov/pubmed/32790733
http://dx.doi.org/10.1371/journal.pone.0237693